Mammalian barrier surfaces house complex commensal communities whose combined membership outnumbers host cells 1 . Recent studies have highlighted the fundamental role of the commensal flora in the control of tissue development and metabolism 2 . Additionally, responsiveness to various pathogens relies on the establishment of a dynamic equilibrium underpinned by the stimulatory capacity of the microbiota. In this context, we and others have demonstrated that defined bacteria or bacteria-derived products can have an adjuvant effect in promoting mucosal immune responses to oral infections and vaccinations 3, 4 . Some of this control relies on the capacity of the flora to activate antigen-presenting cell function, modulate IgA production 5, 6 or stimulate release of a broad spectrum of antimicrobial factors from epithelial cells 7 . However, this stimulatory property of the flora can be a double-edged sword. Indeed, commensals, like pathogens, express a large number of pathogen-associated molecular patterns with strong inflammatory potential 2 . Mucosal tissues, in particular the gastrointestinal tract, are primary sites of infection, and in the context of inflammation, immune reactivity toward the microbiota represents considerable risk to the host 8 . Indeed, aberrant immune responses to commensals have been linked to pathology in a number of mucosal infections 4, 9 and a variety of inflammatory disorders, including Crohn's disease 10 .
In the gastrointestinal tract under steady-state conditions, complementary regulatory elements promote tolerance and control inflammatory responses to the microbiota 11, 12 . These include CD103 + dendritic cells (DCs) that are able to induce regulatory T (T reg ) cells 13, 14 and tissue-resident CD11c + CX3CR1 hi macrophages that constitutively produce the immunoregulatory cytokine interleukin-10 (IL-10) 12 . However, upon pathogen invasion, inflammatory responses must rapidly develop within the mucosal environment, and these responses can be associated with considerable impairments to this endogenous regulatory network [15] [16] [17] . Additionally, during acute inflammation, Ly6C hi inflammatory monocytes and neutrophils become dominant recruited-cell populations 18, 19 . Monocytes and monocyte-derived cell types, such as tumor necrosis factor-α (TNF-α) and inducible nitric oxide synthase (iNOS)-producing (TIP) DCs, are crucial for microbial clearance in a number of mucosal and systemic models, including infection with Citrobacter rodentium 20 , herpes simplex virus 21 , Aspergillus fumigatus 22 , Toxoplasma gondii 23 and Listeria monocytogenes 24 . Neutrophils not only play an important part in microbial clearance but also are responsible for collateral damage to tissue as a result of their capacity to release reactive oxygen species (ROS), superoxides and a number of destructive proteases alongside inflammatory cytokines 25 . Whether specific mechanisms exist to regulate the pathogenic potential of neutrophils during mucosal inflammation is unknown. Moreover, how the delicate balance between the protective and inflammatory role of the flora is controlled in inflammatory settings remains an unanswered question.
Infection with T. gondii is a well-established model used to investigate the balance between pathogen control and collateral damage 26 .
Oral infection of certain strains of mice leads to type 1 helper T (T H 1) cell-mediated intestinal immunopathology characterized by ileitis, in which severity of disease depends on the inflammatory potential of commensal bacteria 9 . However, despite this severe inflammation, T. gondii-infected mice can survive the infectious challenge. We used this model of acute mucosal infection to study dominant regulatory mechanisms of commensal-driven pathology at mucosal sites.
Here, we found that in response to commensal-derived signals, Ly6C hi inflammatory monocytes acquire a regulatory capacity during acute infection and specifically control neutrophil activation. Further, our work shows that monocyte-derived PGE 2 is a principal mediator of immune regulation in the gastrointestinal tract owing to its capacity to directly limit activation of neutrophils. In sum, our work describes a previously uncharacterized regulatory loop in which commensals limit their own pathologic potential by imposing a regulatory phenotype on Ly6C hi inflammatory monocytes. Such features allow these cells to efficiently control parasite expansion while simultaneously limiting collateral damage.
RESULTS

Dominance of inflammatory monocytes during infection
To determine the factors controlling commensal-driven pathology at mucosal sites, we first investigated the dynamics of steady-state regulatory versus recruited inflammatory cells during acute gastrointestinal inflammation. To address this, we used a model of T. gondii infection in which C57BL/6 mice were infected orally with ten cysts of T. gondii ME-49 (C1 clone) 15 . Parasite burden in the gut peaked at day 8 after infection, by which time the mice developed an acute inflammatory response that is associated with rapid weight loss ( Fig. 1a) . In this setting, >80% of mice survived, eventually regaining weight by day 18 after infection. At the acute stage of infection, we observed pronounced alterations to the steady-state regulatory network of the small intestine. Notably, the frequency and absolute number of lamina propria CD11b + CD103 + DCs that contribute to T reg cell induction 13, 14 were substantially reduced ( Fig. 1b,c) . Consistent with this observation, as we have previously described 15 , Foxp3 + T reg cell numbers dropped markedly at the peak of the inflammatory response (Supplementary Fig. 1a ). Furthermore, by day 6 after infection, CD11c + CX3CR1 hi macrophages had downregulated their capacity to make IL-10 ( Supplementary Fig. 1b ).
In concert with these impairments to the regulatory network, Ly6C hi class II major histocompatibility complex (MHCII) hi inflammatory monocytes accumulated in the lamina propria over the course of infection, typically constituting over 50% of total mucosal CD11b + cells by day 8 after infection ( Fig. 1d) . At this time point, Ly6C hi monocytes represented the dominant mononuclear phagocyte population in the small intestine lamina propria (SILP) ( Fig. 1e and Supplementary Fig. 2a,b ) and were the most infected cells in the tissue ( Fig. 1f,g) . Thus, mucosal T. gondii infection resulted in a global impairment of the steady-state regulatory network, concomitant with a pronounced recruitment of Ly6C hi monocytes.
Dual phenotype of inflammatory monocytes during infection
Previous work described parasite killing as the primary function of Ly6C hi monocytes during T. gondii infection 23 . However, given the prevalence of this cell type in the SILP, along with the lack of regulatory cell populations during acute inflammation, we postulated that Ly6C hi monocytes may take on a more complex function. To explore this possibility, we collected SILP Ly6C hi monocytes from the inflamed gut and compared them by microarray analysis to their Ly6C hi blood monocyte precursors 27 from infected mice ( Supplementary Fig. 2c,d) . Consistent with their antiparasitic function, proinflammatory factors, including iNOS 28 and IL-6 (ref. 29) , were upregulated at both the gene and protein levels in SILP Ly6C hi monocytes compared to blood monocytes ( Fig. 2a-c) . Moreover, IL-1α and IL-1β, cytokines that have an effector role in multiple infectious settings, were also upregulated ( Fig. 2a-c) . SILP Ly6C hi monocytes also upregulated expression of various chemokines including CXCL2, CCL3 and CCL4 ( Fig. 2a,b) , which are involved in the recruitment of lymphocytes, neutrophils and monocytes to sites of inflammation. Additionally, although not enhanced at the transcriptional level, TNF-α protein expression was significantly augmented (Fig. 2d ). npg Concomitant with the induction of inflammatory mediators, the expression of numerous gene products with ascribed immunoregulatory potential was also higher in SILP Ly6C hi monocytes compared with Ly6C hi blood monocytes ( Fig. 2a,b,e ). These included IL-10 and arginase-1, which have regulatory functions during T. gondii infection 30, 31 , as well as indoleamine 2,3-dioxygenase 32 . One of the most upregulated genes was Ptgs2, which encodes cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin synthesis 33 (Fig. 2a,b) . We confirmed the production of the lipid mediator PGE 2 by culturing cellsorted Ly6C hi SILP monocytes from T. gondii-infected mice ( Fig. 2f) . PGE 2 has been demonstrated to have suppressive effects on innate cell function 34 . Of note, a large fraction of Ly6C hi SILP monocytes produced both inflammatory and regulatory factors ( Fig. 2g) . Thus, as a likely consequence of their exposure to the inflamed mucosal milieu, Ly6C hi monocytes adopted a mixed phenotype, acquiring both inflammatory and regulatory features.
Commensals induce regulatory phenotype of Ly6C hi monocytes
We next investigated whether such expression of dual features was specific to Ly6C hi monocytes in the SILP milieu. Although T. gondii invades through the gut, it establishes a systemic infection, driving recruitment of inflammatory cells to multiple sites, including the spleen (Supplementary Fig. 3a ). We found that whereas Ly6C hi monocytes from all infected tissues produced TNF-α to a similar extent ( Fig. 3a,b) , IL-10 and PGE 2 were selectively expressed by Ly6C hi monocytes isolated from the gut (Fig. 3a,b) .
A defining feature of mucosal sites is their juxtaposition with an abundant and diverse commensal flora 35 . In particular, during T. gondii infection, the gastrointestinal immune system becomes highly exposed to microbial-derived products resulting from tissue damage and bacterial translocation dominated by γ-proteobacteria such as Escherichia coli 8 (Fig. 3c and data not shown). To assess whether IL-10 and PGE 2 production are induced as a consequence of exposure to commensals, we infected germ-free mice, which are raised and maintained devoid of live microbes, with T. gondii. At day 9 after infection, the ability of small intestine Ly6C hi monocytes to produce IL-10 and PGE 2 was substantially lower in germ-free compared to specific-pathogen-free control mice ( Fig. 3d,e ). To further address the capacity of microbial products to trigger regulatory factors, we stimulated Ly6C hi monocytes from the SILP and spleen with a lysate derived from a commensal strain of E. coli isolated from T. gondii-infected mice. In response to microbial stimulation, splenic Ly6C hi monocytes upregulated their production of IL-10 and PGE 2 , as well as TNF-α, to a similar extent as SILP Ly6C hi monocytes, resulting in a normalization of the phenotype between these two populations ( Fig. 3a,b) . Thus, acquisition of regulatory features is not limited to a subset of Ly6C hi monocytes but is rather the result of commensal-driven activation. More specifically, Ly6C hi monocytes produced TNF-α, IL-10 and PGE 2 in response to a broad range of bacterial-derived ligands, including those recognized by Toll-like receptor 2 (TLR2), TLR4, TLR5 and TLR9 ( Fig. 3f,g and Supplementary Fig. 3b ). Ly6C hi monocytes also responded to the soluble tachyzoite antigen (STAg) of T. gondii and the T. gondii-derived ligand profilin in a proinflammatory manner, as indicated by TNF-α release and limited production of IL-10 or PGE 2 (Fig. 3f,g and Supplementary Fig. 3b ). Together, these data demonstrate that Ly6C hi monocytes acquire the ability to produce IL-10 and PGE 2 at inflamed mucosa and that this response is promoted by commensal exposure.
Ly6C hi monocytes prevent neutrophil-mediated pathology
The unusual phenotype of Ly6C hi monocytes during T. gondii infection suggests that these cells may exert regulatory functions at mucosal sites. To address this possibility, we used Ccr2-deficient mice, which have a defect in monocyte exit from the bone marrow and, hence, decreased accumulation of monocytes in tissue 36 . Before infection, the numbers, frequencies and activation levels of DC subsets, macrophages, neutrophils and CD4 + T cells were identical in the gastrointestinal tract of Ccr2-deficient mice compared to wild-type (WT) controls (data not shown and Supplementary Fig. 4 ). As expected, npg by day 8 after infection, we observed pronounced differences in the frequencies of Ly6C hi MHCII hi monocytes and Ly6G + neutrophils in the gut (Fig. 4a) . Further, T. gondii infection in Ccr2-deficient mice was characterized by more severe mucosal pathology than that seen in WT mouse controls, as evidenced by marked destruction of the crypt architecture and influx of inflammatory cells ( Fig. 4b and Supplementary Fig. 5a ). As previously described for WT mice, in Ccr2-deficient mice, T. gondii-mediated pathology is dependent on neutrophils 37 , commensals 9 and TNF-α 47 (Supplementary Fig. 5 ).
Although previous reports suggested that the increased pathology in Ccr2 −/− mice was associated with uncontrolled parasite expansion, we found marked changes in neutrophil activation before we detected changes in parasite burden in the gut and other sites (Fig. 4c,d and Supplementary Fig. 6a-c) . Increased activation of neutrophils was characterized by a greater frequency of neutrophils expressing TNF-α, IL-6, IL-1α and IL-1β at a higher mean fluorescence intensity (MFI) in Ccr2-deficient mice compared to WT mice ( Fig. 4d-g) . Notably, production of ROS, a major driver of immunopathology 38 , was also significantly higher in neutrophils from Ccr2 −/− mice compared to WT mice ( Fig. 4e,h) . These changes in neutrophil activation were not associated with changes in absolute numbers of neutrophils, frequencies of DC or resident macrophage subsets, T H 1 responses or aberrant increases in parasitic load ( Supplementary Fig. 6 ). Altogether, we suggest these data support the idea that in addition to their previously described role in parasite killing, Ly6C hi monocytes may also limit neutrophil-mediated mucosal immunopathology.
Ly6C hi monocytes directly regulate neutrophil activation Neutrophils and TNF-α are major drivers of mucosal pathology, including during T. gondii infection 37, 39 . Consistent with a pathogenic role for neutrophils in response to commensals, they produced a robust TNF-α response to E. coli lysate but failed to express PGE 2 or respond to T. gondii products ( Supplementary Figs. 7 and 8b) . We hypothesized that neutrophils could represent a direct target for the npg regulatory effect of Ly6C hi monocytes. In support of this, monocytes and neutrophils, which both express lysozyme, localize in discrete foci along the infected gut ( Fig. 5a-c) .
We first assessed whether, in vitro, factors secreted by monocytes were capable of controlling commensal-driven neutrophil activation. To this end, we cultured cell-sorted Ly6C hi monocytes overnight in the presence of E. coli lysate and collected their supernatant. Notably, subsequent exposure of purified neutrophils to Ly6C hi monocyte supernatant, but not to neutrophil supernatant, significantly reduced their ability to produce TNF-α in response to activating stimuli ( Fig. 5d,e ).
Although the factors regulating neutrophils have been poorly explored, some reports have suggested the involvement of IL-10 (ref. 40) , transforming growth factor-β (TGF-β) 41 , IL-27 (ref. 42 ), adenosine 43 and PGE 2 (ref. 44 ) in neutrophil regulation. By using blocking antibodies or inhibitors targeting the activity of these factors in vitro, we assessed the extent of their involvement in mediating the suppressive effects of Ly6C hi monocytes. Using this approach, we excluded a role for TGF-β, adenosine and IL-27 in the aforementioned suppressive effect (Fig. 5f) . Although antibody inhibition of IL-10 receptor (IL-10R) signaling had a small but significant effect on TNF-α production by neutrophils, the observed effect could not account for the overall inhibition obtained with Ly6C hi monocyte supernatant (Fig. 5f) . Notably, preincubation of neutrophils with inhibitors of PGE 2 receptors (EP2 and EP4 (ref. 45)) completely abrogated the suppressive effect of Ly6C hi monocyte supernatant on neutrophils ( Fig. 5g) . Further, treatment of Ly6C hi monocytes with indomethacin, which inhibits COX-1 and COX-2, the rate-limiting enzymes in PGE 2 synthesis, reversed the suppressive phenotype observed with Ly6C hi monocyte supernatant (Fig. 5h) .
Complementing these findings, we found that at the acute stage of T. gondii infection, Ly6C hi monocytes that represent the dominant cell type in the inflamed gut are also the main source of PGE 2 in the lamina propria ( Figs. 1e and 5i ) and that treatment of neutrophils with increasing concentrations of purified PGE 2 potently suppressed their capacity to produce TNF-α or ROS ( Fig. 5j) . Of relevance to human settings, CD14 + monocytes isolated from human peripheral blood mononuclear cells (PBMCs), but not neutrophils, also produced large amounts of PGE 2 in response to commensal stimuli. Moreover, PGE 2 suppresses human neutrophil activation in vitro ( Supplementary  Fig. 8 ). Together, these data demonstrate that PGE 2 is a potent suppressor of neutrophil activation in vitro and that activated Ly6C hi monocytes can directly inhibit commensal-driven neutrophil activation in a PGE 2 -dependent manner.
PGE 2 regulates neutrophil activation in vivo
We next investigated the role of PGE 2 and Ly6C hi inflammatory monocytes in the regulation of neutrophil activation and gut immunopathology during acute inflammation. As previously reported, inflammatory monocytes poorly accumulate in tissues after transfer (data not shown) 19, 21 . Thus, to address the capacity of Ly6C hi monocytes to suppress neutrophil activation in vivo, we took advantage of an alternative model of T. gondii infection. To this end, we infected Ccr2-deficient mice with parasite cysts by intraperitoneal (i.p.) injection 46 . To mimic the dominant gut commensal signal, we then injected the mice with E. coli lysate i.p. 4 d after infection (Supplementary Fig. 9a) . Notably, i.p. injection of preactivated Ly6C hi monocytes prior to E. coli treatment markedly suppressed the capacity of neutrophils to produce TNF-α in response to commensals (Fig. 6a,b) . To link this suppression to the capacity of Ly6C hi monocytes to produce PGE 2 , we preincubated these cells with nonsteroidal anti-inflammatory drugs (NSAIDs): indomethacin, a COX-1 and COX-2 inhibitor, or celecoxib, which specifically inhibits COX-2 activity 47 . In both cases, the capacity of Ly6C hi monocytes to suppress neutrophil activation in vivo was abolished ( Fig. 6a,b) . These results demonstrate that in vivo, the capacity of Ly6C hi monocytes to suppress neutrophil activation depends on the ability of these cells to produce PGE 2 in response to commensal stimuli. We further explored the capacity of a long-lived analog of PGE 2 (16,16-dimethyl PGE 2 (diMePGE 2 )) 48 to regulate neutrophil activity and pathology during T. gondii infection. Short-term diMePGE 2 treatment of WT mice, from day 6 to day 8 after infection, had no effect on parasite burden but led to decreased tissue pathology and reduced efflux of inflammatory cells into the lumen (Supplementary Fig. 9b,g) . We next assessed whether PGE 2 could compensate for a lack of Ly6C hi monocytes in Ccr2 −/− mice. Notably, treatment of Ccr2-deficient mice with diMePGE 2 significantly reduced the capacity of neutrophils to produce TNF-α and ROS and reduced mucosal pathology ( Fig. 6c-e ). These changes in neutrophil activation were not associated with alterations in their absolute number, degree of parasite infection or changes in effector T cell polarization (Supplementary Fig. 9c-e) .
We next explored the possibility that adverse reactions of drugs limiting COX activity (NSAIDs) 49 could be associated with aberrant neutrophil activation in the inflamed mucosa. To experimentally test this possibility, we blocked PGE 2 production during infection by treating mice with indomethacin or celecoxib. In support of a regulatory role for PGE 2 , NSAID treatment led to augmented TNF-α and ROS production by neutrophils and enhanced mucosal and liver pathology ( Fig. 6f-h) . Notably, treatment with indomethacin or celecoxib was associated with increased mortality after T. gondii infection ( Fig. 6i) . Increased mortality was not associated with changes in parasite numbers (Supplementary Fig. 9f,g) .
Altogether, these data demonstrate that during mucosal inflammation, PGE 2 , and in particular Ly6C hi monocyte-derived PGE 2 , represents a powerful regulatory arm capable of limiting lethal neutrophil-mediated immunopathology, and that impairment of this regulatory pathway can lead to severe pathological consequences (Supplementary Fig. 10 ).
DISCUSSION
Our work describes a previously uncharacterized regulatory loop at mucosal sites in which commensals trigger a program involved in limiting their own pathogenic potential. In particular, we show that (i) recruited inflammatory monocytes take on tissue-specific regulatory features in response to commensal stimuli, (ii) inflammatory monocytes control neutrophil pathogenic potential and (iii) neutrophil activation is specifically inhibited by PGE 2 derived from Ly6C hi inflammatory monocytes at mucosal sites.
Numerous studies have proposed an inflammatory role for Ly6C hi monocytes. For instance, after chemical-induced injury in the gut, Ly6C hi monocytes can contribute to the pathological process by promoting inflammation 19 . Further, Ly6C hi monocytes have a dominant role in the control of the invading pathogen in various settings 18, . Here, we found that Ly6C hi monocytes also acquire a major regulatory role in the inflamed gut during acute infection. Although our work does not dispute a role for Ly6C hi monocytes in parasite killing, npg it adds another layer of complexity to their function by revealing their crucial role in regulating mucosal inflammation. The microbiota modulates various aspects of immune responses and can enhance protection against pathogens 2,3,50 . However, the flora is also a major contributor to inflammatory disorders, including Crohn's disease 2 . During infection-induced inflammation, commensals can also directly contribute to neutrophil-mediated tissue damage 9 . Supporting this, we found that neutrophils strongly responded to commensal, but not T. gondii-derived, ligands in a proinflammatory manner. Such a response highlights the dominant role of neutrophils in controlling bacterial translocation 25, 51 . Despite the central role of neutrophils in driving mucosal pathology, the mechanisms modulating the delicate balance between their role in commensal control and their involvement in tissue damage are poorly understood.
We showed here that regulation of commensal-induced pathology is triggered by commensals themselves in an autoregulatory loop. Indeed, we found that Ly6C hi monocytes produce various regulatory factors including IL-10 and the lipid mediator PGE 2 specifically in the gut mucosa in response to commensals both in vitro and in vivo. Similarly, high amounts of PGE 2 can be elicited from human CD14 + blood monocytes in response to commensal stimuli. Acquisition of regulatory features by highly activated effector cells has been well documented in effector T cells in which highly polarized T H 1 cells produce IL-10 in tandem with interferon-γ 52, 53 . Paralleling this, we found that Ly6C hi monocytes entering the gastrointestinal tract responded to commensal ligands by adopting a regulatory phenotype. As previously described for activated T cells 52, 53 , acquisition of regulatory and inflammatory function endows Ly6C hi monocytes with the dual capacity to control parasite burden while limiting collateral damage to tissue.
Ly6C hi blood monocytes can differentiate into CD11c + TIP DCs in the spleen in response to inflammation 24 . Here, we found that during T. gondii infection, TIP DCs were also highly represented in the spleen. Conversely, myeloid-derived suppressor cells, a common cell type in cancer 54 and sepsis 55 , can also arise from Ly6C hi monocytes. Our present data are, to our knowledge, the first demonstration of a direct role for inflammatory monocytes in controlling neutrophil function and gut pathology.
Multiple layers of regulation are required to limit mucosal damage during acute inflammation 2 . A number of studies have focused on the role of PGE 2 in the resolution of inflammation and in chronic inflammatory conditions, but its mechanisms of regulation during an acute response are less well understood 56 . Our work proposes that owing to its capacity to target neutrophils at the acute stage of the npg immune response, the lipid mediator PGE 2 controls mucosal pathology. The capacity of Ly6C hi monocytes to also produce IL-10, arginase and indoleamine 2,3-dioxygenase strongly suggests that these cells can exert additional regulatory functions in the gut. Further, during mucosal inflammation, the effect of PGE 2 is likely to extend beyond neutrophils, as this molecule can control a large array of cell populations. Indeed, PGE 2 has been linked to the maintenance of the gut epithelial layer and has pleiotropic effects on the immune system, including modulation of DC activation, suppression of natural killer cell function and alterations to effector T cell polarization 34 .
Of high relevance to clinical settings, genome-wide association studies linked both TNF-α and pathways associated with the production of ROS to the etiology of inflammatory bowel disease 57 . Crohn's diseaseassociated alleles also correlate with expression levels of PGE 2 receptors 58 , whereas suppression of prostaglandin synthesis by NSAIDs is associated with gastrointestinal damage 49 . Despite the extensive use of NSAIDs, such as aspirin, in the clinic, the mode of action and cellular targets of these inhibitors remains unclear. Here, the capacity of Ly6C hi monocytes to control neutrophil function, and in particular the production of TNF-α and ROS by neutrophils, implies that impaired monocyte-derived PGE 2 production may have a role in multiple gut pathologies. Additionally, these results support the idea that modulating PGE 2 metabolism or monocyte recruitment in inflamed tissues needs to be considered in a highly contextual manner.
Overall, our findings identify PGE 2 as a key mediator of commensalinduced regulation during inflammation. This adds an additional layer to understanding of the complex actions of lipid mediators in modulating the immune response. Moreover, our data suggest that targeting PGE 2 metabolism may represent an important future therapeutic approach in the treatment of mucosal inflammatory diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Microarray data have been deposited in the Gene
Expression Omnibus database with accession code yy.
ONLINE METHODS
Mice. Female C57BL/6 WT mice were purchased from Taconic Farms or Jackson Laboratories. B6.129S4-Ccr2 tm1Ifc /J (Ccr2 −/− ) mice and B6.129P(Cg)-Ptprc a Cx3cr1 tm1Litt /LittJ (CX3CR1-GFP) mice were purchased from Jackson Laboratories. Lysozyme M eGFP transgenic mice (C57BL/6NTac-Lysozyme, Tac Line 342) and CD11c YFP (C57BL/6-[Tg]CD11c:EYFP, Tac Line 307) transgenic mice were obtained through the Taconic NIAID exchange. Mice were bred in-house to generate the LysM eGFP × CD11c YFP strain. Germ-free C57BL/6 mice were bred at Taconic Farms and maintained in the NIAID gnotobiotic animal facility. All mice were bred and maintained under pathogen-free conditions at an American Association for the Accreditation of Laboratory Animal Care-accredited animal facility at the NIAID and housed in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals. All experiments were performed at the NIAID under an animal study proposal approved by the NIAID Animal Care and Use Committee. Gender-and age-matched mice aged 8-16 weeks were used.
Human subjects. Whole blood was obtained from healthy donors under NIAID Institutional Review Board-approved protocols from the Department of Transfusion Medicine (Clinical Center, National Institutes of Health). All subjects signed written informed consent forms.
Parasite and infection protocol. ME-49 clone C1 of T. gondii (provided by M.E. Grigg) was obtained by electroporation of the parental ME-49 type II strain (ATCC 50840) with red fluorescent protein (RFP) and was used for production of tissue cysts in C57BL/6 mice. Tissue cysts used in experiments were obtained from female mice that were perorally inoculated with ten cysts 2-3 months earlier. Mice were killed and their brains removed and homogenized in 1 ml of PBS pH 7.2. Cysts were counted on an inverted fluorescent microscope. Average cyst count was calculated from two aliquots of 20 µl. For experiments, female mice were either infected by intragastric gavage with ten cysts of ME-49 C1 or injected i.p. with 20 cysts of the same parasite. Soluble tachyzoite antigen (STAg) was prepared as previously described 59 .
Antibody treatment. For depletion of neutrophils and inhibition of TNF-α, Ccr2 −/− mice were injected i.p. with anti-Gr1 antibody (clone RB6-8C5 (ref. 60 ), 500 µg), anti-TNF-α antibody (clone MP6-XT22 61 , 1 mg) or rat IgG isotype control on days 5 and 8 after infection.
Antibiotic treatment. Female Ccr2 −/− mice aged 6-8 weeks were provided ampicillin (1 g/l), vancomycin (500 mg/l), neomycin trisulfate (1 g/l) and metronidazole (1 g/l) in drinking water as previously described 62 . All antibiotics were purchased from Sigma-Aldrich.
Quantification of parasite tissue loads by plaque assay. Cultures of human fibroblasts (Hs27; American Type Culture Collection no. CRL-1634) were used for parasite burden quantification as previously described 63, 64 . Single-cell tissue suspensions (10 6 cells or 100 µl of sample) were added to the fibroblast monolayer cultures and titrated for plaque formation. The results of these titrations are reported in plaque-forming units (PFUs).
Phenotypic analysis. Cells from lamina propria or spleen were prepared as previously described 14 . Single-cell suspensions were incubated with an anti-FcγIII/II receptor antibody (clone 93), purified rat immunoglobulin (Jackson ImmunoResearch) and mouse serum (Jackson ImmunoResearch). Cells were stained with fluorochrome-conjugated antibodies against surface markers CD11c (N418) (1 in 200), CD11b (M1/70) (1 in 1,000), MHCII (I-A/I-E) (M5/114) (1 in 300), Ly6C (HK1.4) (1 in 800), Ly6G (1A8) (1 in 300), CD103 (2E7) (1/300) and F4/80 (BM8) (1 in 100) in PBS containing 1% FBS for 15 min on ice and then washed. Dead cells were excluded using 4′,6-diamidino-2-phenylindole (DAPI) dihydrochloride (Sigma). All antibodies were purchased from BD Biosciences or eBioscience. Cell acquisition was performed on an LSRII machine using FACSDiVa software (BD Biosciences). For each sample, at least 300,000 events were collected. Data were analyzed with FlowJo software (TreeStar).
In vitro restimulation of innate cells and intracellular cytokine detection.
RPMI 1640 supplemented with 10% FBS, penicillin, streptomycin, HEPES, glutamine, nonessential amino acids and 50 mM of β-mercaptoethanol (complete medium) was used for in vitro restimulation. For ex vivo cytokine detection in lamina propria or spleen, single-cell suspensions were cultured at 5 × 10 5 -1 × 10 6 cells per well in 96-well round-bottom plates in the presence of brefeldin A alone (GolgiPlug, BD Biosciences). In some cases, single-cell suspensions were stimulated with commensal or parasite-derived ligands in combination with brefeldin A. After 3 h, cells were surface stained for Ly6C (HK1.4), Ly6G (1A8), MHCII (I-A/I-E) (M5/114) and CD11b (M1/70), then washed twice with FACS buffer and fixed in a solution of 2% paraformaldehyde (Electron Microscopy Sciences). Before fixation, Live/Dead Fixable Blue Cell Stain Kit (Invitrogen) was used to exclude dead cells. Cells were then stained with fluorochromeconjugated antibodies against inducible nitric oxide synthase (iNOS) (polyclonal rabbit) (1 in 500), TNF-α (MP6-XT22) (1 in 400), IL-1α (ALF-161) (1 in 200), IL-1β (NJTEN3) (1 in 400), IL-6 (MP5-20F3) (1 in 200) and IL-10 (JES5-16E3) (1 in 200), or their appropriate isotype controls rat IgG1, rat IgG2b or Armenian hamster IgG in the presence of anti-FcγIII/II receptor for 60 min in FACS buffer containing 0.5% saponin. All antibodies were purchased from BD Biosciences or eBioscience.
Ly6C hi inflammatory monocyte, macrophage and neutrophil purification.
Monocytes, macrophages and neutrophils were purified from pooled single-cell suspensions of naive or T. gondii-infected blood, spleen or lamina propria. Blood was lysed and washed. Spleen or lamina propria digests were passed through 70-µm and 40-µm cell strainers, centrifuged and cells were resuspended in 1.077 g/cm 3 iso-osmotic NycoPrep medium (Accurate Chemical & Scientific Corporation) and overlaid with RPMI 1640. The low-density fraction was collected after centrifugation at 1,650g for 15 min. Cells were incubated with mixture of monoclonal antibodies containing anti-FcγIII/II and 7-AAD viability staining solution.
Stimulation of FACS-purified populations.
Purified Ly6C hi inflammatory monocytes and neutrophils were cultured in complete medium at 2 × 10 4 -2 × 10 5 cells per well in a 96-well round-bottom plate. In some cases, cells were stimulated with E. coli lysate (5 µg/ml), soluble tachyzoite antigen (STAg) (5 µg/ml) or the commercially available TLR ligands Pam2CSK4, LPS, flagellin, CpG (all from Invivogen) (1 µg/ml) or profilin (Alexis Biochemicals) (1 µg/ml) for 18 h. Supernatants were assayed for IL-10 or TNF-α using the DuoSET ELISA system (R&D Systems), or PGE 2 using an enzyme-immunoassay (EIA) (Cayman Chemicals), as per manufacturers' instructions.
Human monocyte and neutrophil isolation and culture. Peripheral venous blood was obtained from healthy adult subjects. Monocytes were isolated from the peripheral blood mononuclear cell (PBMC) layer. An ammonium chloridebased lysis was performed to remove erythrocytes. PBMCs were then stained in FACS buffer containing mouse serum with monoclonal antibodies to CD14 (M5E2) (1 in 50) and HLA-DR (G46-6) (1 in 20) for sorting. For neutrophil isolation, after isolation on a Ficoll gradient, erythrocytes were removed by two rounds of hypotonic lysis with ice-cold double-distilled H 2 O to keep the granulocytes within physiological conditions. Neutrophils were stained with an antibody to CD16 (3GB) (1 in 25) for FACS sorting. Purified monocytes and neutrophils were stimulated at 1 × 10 6 cells/ml overnight with or without E. coli lysate (5 µg/ml). PGE 2 production was assessed in supernatants by EIA. All antibodies were purchased from BD Biosciences.
Human neutrophil suppression by PGE 2 .
Human neutrophil production of ROS was assessed by flow cytometry after stimulation with N-formyl-Met-Leu-Phe (fMLP) (10 µM) (Sigma) in the presence of increasing concentrations of PGE 2 . Alternatively, neutrophils were cultured overnight at 1 × 10 6 cells/ml and stimulated with E. coli lysate (5 µg/ml) in the presence or absence of PGE 2 . After overnight culture, TNF-α was measured in supernatants using a human TNF-α DuoSet ELISA system (R&D Systems).
Detection of reactive oxygen species.
Single-cell suspensions from small intestine lamina propria (SILP) or human blood FACS-purified neutrophils were plated at 5 × 10 5 or 3 × 10 4 -5 × 10 4 cells, respectively, in 96-well roundbottom plates and resuspended in complete medium containing 2 ng/ml npg dihydrorhodamine 123 (Invitrogen). Cells were incubated for 30 min at 37 °C in the presence or absence of fMLP (10 µM) and then washed with FACS buffer before being stained for the surface markers Ly6G (1A8), Ly6C (HK1.4) and CD11b (M1/70) to identify neutrophils. DAPI was used to exclude dead cells. Cell acquisition was performed on an LSRII machine using FACSDiVa software (BD Biosciences). For each sample, at least 300,000 events were collected. Data were analyzed with FlowJo software (TreeStar).
Ly6C hi inflammatory monocyte suppression assay. Ly6C hi inflammatory monocytes were FACS-purified from the SILP of T. gondii-infected mice at day 8 after infection and then stimulated overnight with E. coli lysate (5 µg/ml) in complete medium. The COX-1 and COX-2 inhibitor indomethacin (10 µM) (Sigma) was added to some cultures. Overnight supernatants were removed and used to treat FACS-purified bone marrow neutrophils that were activated with E. coli lysate (2 µg/ml) in the presence of brefeldin A. In some cases, antibodies against cytokines and cytokine receptors: anti-TGF-β (1D11) (10 µg/ml) (BD Biosciences), anti-IL-10R (1B1.3a) (10 µg/ml) (BD Biosciences), anti-IL-27 (polyclonal goat) (10 µg/ml) (R&D Systems); inhibitor of adenosine receptor signaling xanthine amine congener (XAc) (1µM); or inhibitors of PGE 2 -receptors EP2 (AH-6809) (10 µM) and EP4 (AH-23848) (10 µM) (Cayman Chemicals) were included at the start of the assay. After 3-h stimulation, neutrophils were fixed and stained for intracellular cytokines.
In vivo neutrophil suppression assay. Mice were infected i.p. with 20 cysts C1-RFP T. gondii. At day 4 after infection, 1 × 10 6 -2 × 10 6 FACS-sorted bone marrow Ly6C hi monocytes isolated from orally infected mice at day 6 after infection were transferred i.p. Before transfer, monocytes were stimulated for 30 min with E. coli lysate in the presence of indomethacin (10 µM), celecoxib (25 µM) or DMSO vehicle control. After monocyte transfer, peritoneal cells were activated by i.p. E. coli lysate injection (2 µg/mouse). Mice were lavaged 30 min later with 6 ml of ice-cold PBS, and neutrophil production of TNF-α was assessed by intracellular cytokine staining after 3-h culture with brefeldin A.
16,16-Dimethyl prostaglandin E 2 , indomethacin and celecoxib treatment.
Mice that were orally infected with ten cysts of T. gondii were treated once daily starting on day 6 after infection with an i.p. injection of diMePGE 2 (12 µg per kg body weight) (Cayman Chemicals), indomethacin (3 mg per kg body weight) or celecoxib (15 mg per kg body weight) (Sigma). Untreated mice received a DMSO vehicle control.
Pathology assessment. Mice were killed at days 8-10 after infection. Small intestines were removed and sections of the jejunum and ileum immediately fixed in a 10% formalin solution. Paraffin-embedded sections were cut longitudinally at 0.5 µm and stained with H&E. The sections were examined histologically and a semiquantitative 15-point assessment combining scores for inflammatory infiltrate, crypt architecture and mucosal surface involvement was made. Scoring was evaluated on the following modified scale 9, 15 . For inflammatory infiltrate score, 0 = occasional or no infiltrate, 1 = minimal inflammatory leukocyte or granulocyte infiltration locally or multifocally, 2 = mild inflammatory leukocytic or granulocytic infiltrates within the lamina propria, 3 = mild-to-moderate inflammatory infiltrates in the lamina propria and submucosa, 4 = moderate-tomarked inflammatory infiltrates admixed with cellular debris within the lamina propria and submucosa and 5 = marked-to-severe inflammation diffusely with abundant inflammatory infiltrates extending transmurally. For crypt architecture score, 0 = occasional or no crypt involvement, 1 = one-third of lower crypt involved in inflammation, 2 = two-thirds of crypt involved, 3 = entire length of crypt involved, 4 = entire length of crypt involved with loss of crypt separation and 5 = complete loss of normal histologic crypt structure with deep mucosal ulceration present. For mucosal surface involvement score, 0 = no involvement, 1 = 1-5% of area scored, 2 = 5-10% of area scored, 3 = 10-20% of area scored, 4 = 20-50% of area scored and 5 = >50% of area scored. Grading was performed in a blinded fashion by I.J.F. For each mouse, at least two sections 100 µm apart were evaluated.
Fluorescence in situ hybridization. For fluorescence in situ hybridization (FISH), the small intestines were prepared by fixation in 60% methanol, 30% chloroform, 10% acetic acid, then washed in 70% ethanol and embedded in paraffin. Longitudinal sections 5 µm in width were hybridized to a bacterial 16S rRNA gene probe [AminoC6+Alexa488]-GCTGCCTCCCGTAGGAGT-[AmC7_Q+Alexa488] as previously published 65 and counterstained with DAPI. Sections were then visualized on a Leica TCS SP8 microscope.
Confocal analysis.
Jejunal and ileal sections from T. gondii-infected LysM eGFP × CD11c YFP mice were whole-mounted for imaging. Briefly, the small intestines were removed, cut open longitudinally and washed in PBS. Intestinal tissue was fixed overnight in 4% paraformaldehyde solution (Electron Microscopy Sciences) and then stained with Hoechst 33342 (Invitrogen), followed by mounting with Prolong Gold (Invitrogen). Images were collected on a Leica TCS SP5 microscope and processing performed using Imaris software (Bitplane).
Microarray gene-expression profiling and data normalization. Ly6C hi SILP inflammatory monocytes or Ly6C hi blood monocytes were purified by FACS from the SILP and blood of T. gondii-infected mice on day 8 after infection. Three biological replicates containing 5 × 10 4 -1 × 10 5 cells were sorted for each sample. Post-sort purity was >95%. Cells were resuspended in TRIzol (Invitrogen), and then mRNA was isolated and amplified before being hybridized to an Illumina MouseRef BeadChip. Density plots and principal components analysis were used to check the data for any outlier chips or samples. Global median normalization was used to remove array and sample effects from the expression data. Probes with mean log 2 expression ≤6 or log 2 expression s.d. ≤0.5 were removed to eliminate any probes that were below detection threshold or potentially uninformative housekeeping genes. When multiple probes represented the same gene symbol, the probes were averaged together to simplify graphics and statistical results. Log 2 expression values of Ly6C hi blood monocytes were plotted against log 2 expressions of Ly6C hi SILP monocytes. Differential expression ratio of Ly6C hi blood monocytes to Ly6C hi SILP monocytes was tested with Student's t-test, an empirical Bayes's moderated t-test and significance analysis of microarrays (SAM). Differentially expressed genes were identified by volcano plot and heat map.
Statistical analyses.
Groups were compared with Prism software (GraphPad) using a two-tailed unpaired Student's t-test. Data are presented as mean ± s.e.m.
